XTX Topco’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$126K	Buy	+106,119	New	+$126K	0.01%	1831
2024 Q3	–	Sell	-10,493	Closed	-$60.9K	–	2022
2024 Q2	$60.9K	Buy	+10,493	New	+$60.9K	0.01%	1487